MétaCan
Menu
Back to cohort
Record W4284988981 · doi:10.1002/mds.29133

The Interaction between <scp><i>HLA‐DRB1</i></scp> and Smoking in Parkinson's Disease Revisited

2022· article· en· W4284988981 on OpenAlexafffund
Cloé Domenighetti, Venceslas Douillard, Pierre‐Emmanuel Sugier, Ashwin Ashok Kumar Sreelatha, Claudia Schulte, Sandeep Grover, Patrick May, Dheeraj Reddy Bobbili, Milena Radivojkov‐Blagojevic, Peter Lichtner, Andrew B. Singleton, Dena G. Hernandez, Connor Edsall, Pierre‐Antoine Gourraud, George D. Mellick, Alexander Zimprich, Walter Pirker, Ekaterina Rogaeva, Anthony E. Lang, Sulev Kõks, Pille Taba, Suzanne Lesage, Alexis Brice, Jean‐Christophe Corvol, Marie‐Christine Chartier‐Harlin, Eugénie Mutez, Kathrin Brockmann, Angela Deutschländer, G. Hadjigeorgiou, Efthimos Dardiotis, Leonidas Stefanis, Athina Maria Simitsi, Enza Maria Valente, Simona Petrucci, Stefano Duga, Letizia Straniero, Anna Zecchinelli, Gianni Pezzoli, Laura Brighina, Carlo Ferrarese, Grazia Annesi, Andrea Quattrone, Monica Gagliardi, Hirotaka Matsuo, Akiyoshi Nakayama, Nobutaka Hattori, Kenya Nishioka, Sun Ju Chung, Yun Joong Kim, Pierre Kolber, Bart P.C. van de Warrenburg, Bastiaan R. Bloem, Jan Aasly, Mathias Toft, Lasse Pihlstrøm, Leonor Correia Guedes, Joaquim J. Ferreira, Soraya Bardien, Jonathan Carr, Eduardo Tolosa, Mario Ezquerra, Pau Pástor, Mónica Díez-Fairén, Karin Wirdefeldt, Nancy L. Pedersen, Caroline Ran, Andrea Carmine Belin, Andreas Puschmann, Emil Ygland, Carl E Clarke, Karen Morrison, Manuela Tan, Dimitri Krainc, Lena F. Burbulla, Matthew J. Farrer, Rejko Krüger, Thomas Gasser, Manu Sharma, Nicolas Vince, Alexis Elbaz

Bibliographic record

VenueMovement Disorders · 2022
Typearticle
Languageen
FieldMedicine
TopicParkinson's Disease Mechanisms and Treatments
Canadian institutionsOntario Brain InstituteToronto Western HospitalOccupational Cancer Research CentreUniversity of Toronto
FundersNational Institute of Environmental Health SciencesNational Institute on AgingFaculty of Medicine and Health, University of SydneyInstituto de Salud Carlos IIIMedical Research CouncilPfizer JapanNovartis PharmaParkinsonfondenNational Institutes of HealthParkinson VerenigingOno PharmaceuticalFP Pharmaceutical CorporationMitsubishi Tanabe Pharma CorporationSkånes universitetssjukhusAssociation France ParkinsonMedical Research Council CanadaLunds UniversitetNorges ForskningsrådDepartment of Forestry and Natural Resources, Purdue UniversityEuropean CommissionFondazione Pierfranco e Luisa MarianiMinistero della SaluteHelse Sør-Øst RHFSanofi K.K.Eesti TeadusagentuurDaiichi Sankyo EuropeKarolinska InstitutetZonMwBiogenAgence Nationale de la RechercheSanofiFondation de FranceIdorsia PharmaceuticalsUniversité Paris-SaclayDepartment of Science and Technology, Ministry of Science and Technology, IndiaFondation Roger de SpoelberchSouth African Medical Research CouncilHersenstichtingRadboud UniversiteitNational Research FoundationUniversity College LondonVerily Life SciencesUniversiteit StellenboschParkinson's UKBundesministerium für Bildung und ForschungNasjonalforeningen for FolkehelsenBoehringer Ingelheim JapanFondazione CariploKisseiAlexion PharmaceuticalsEVER Neuro PharmaNihon Medi-PhysicsUniversité du LuxembourgPfizerEU Joint Programme – Neurodegenerative Disease ResearchTeva Pharmaceutical IndustriesJapan Society for the Promotion of ScienceAstellas PharmaHorizon 2020 Framework ProgrammeVetenskapsrådetEisaiBoston Scientific JapanDeutsche ForschungsgemeinschaftJapan Agency for Medical Research and DevelopmentCentro de Investigación Biomédica en Red sobre Enfermedades NeurodegenerativasMinisterio de Ciencia e InnovaciónUCB PharmaDemensfondenMeiji Seika PharmaHjärnfondenU.S. Department of DefenseMylanBoston Scientific CorporationMichael J. Fox Foundation for Parkinson's ResearchMultiple Sclerosis Society of Western AustraliaConsortium canadien en neurodégénérescence associée au vieillissementHellenic Foundation for Research and InnovationGeneral Secretariat for Research and TechnologyMultiple System Atrophy CoalitionU.S. Department of Health and Human Services
KeywordsOdds ratioParkinson's diseaseSingle-nucleotide polymorphismConfidence intervalDiseasePsychologyMendelian randomizationHuman leukocyte antigenGeneticsMedicineInternal medicineBiologyGenotypeGeneAntigen

Abstract

fetched live from OpenAlex

Abstract Background Two studies that examined the interaction between HLA‐DRB1 and smoking in Parkinson's disease (PD) yielded findings in opposite directions. Objective To perform a large‐scale independent replication of the HLA‐DRB1 × smoking interaction. Methods We genotyped 182 single nucleotide polymorphism (SNPs) associated with smoking initiation in 12 424 cases and 9480 controls to perform a Mendelian randomization (MR) analysis in strata defined by HLA‐DRB1 . Results At the amino acid level, a valine at position 11 (V11) in HLA‐DRB1 displayed the strongest association with PD. MR showed an inverse association between genetically predicted smoking initiation and PD only in absence of V11 (odds ratio, 0.74, 95% confidence interval, 0.59–0.93, P Interaction = 0.028). In silico predictions of the influence of V11 and smoking‐induced modifications of α‐synuclein on binding affinity showed findings consistent with this interaction pattern. Conclusions Despite being one of the most robust findings in PD research, the mechanisms underlying the inverse association between smoking and PD remain unknown. Our findings may help better understand this association. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.302
Threshold uncertainty score0.661

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0010.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.014
GPT teacher head0.259
Teacher spread0.245 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations14
Published2022
Admission routes2
Has abstractyes

Explore more

Same venueMovement DisordersSame topicParkinson's Disease Mechanisms and TreatmentsFrench-language works237,207